Delivery Order SPE2DB20D3101-SPE2DB24FQST2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,815.02 firm fixed price delivery order is for the supply of 60 tablets of the prescription drug Briviact 100 mg. The contract has an ultimate completion date of March 26, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 60 tablets of the medication Briviact 50 mg. The firm-fixed-price delivery order is valued at $4,964.40 and has a completion date of March 24, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 25 mg tablets. The contract, valued at $2,484.06, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 100 mg tablets. The contract has a ceiling value of $1,655.44 and an ultimate completion date of September 11, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a value of $2,239.43, is for the procurement of the drug Briviact 50 mg tablets. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product Briviact 100 mg tablet in 60 count packages. The $2,327.91 firm fixed-price delivery order (SPE2DB22FT61D) has an ultimate completion date of August 15, 2022. AmerisourceBergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,068.67, is a delivery order for the medication Briviact 100 mg tablet. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,054.99 firm fixed-price delivery order is for the supply of 60 tablets of the prescription drug BRIVIACT 25 MG. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,979.11 firm fixed-price delivery order is for the supply of BRIVIACT 50 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,056.74 firm fixed-price delivery order is for the supply of 60 tablets of the drug Briviact 50 mg. The contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQST2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Briviact in 100 mg tablet form. The $2,871.03 firm fixed-price delivery order has an ultimate completion date of October 12, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/11/23 |